Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Imiquimod 3.75% cream following cryosurgery for actinic keratoses
NCT00894647Phase 3Completed
- Sponsor
- Graceway Pharmaceuticals
- Start
- May 2009
- Primary completion
- Feb 2010
- Modality
- Nucleic Acid-Directed Small Molecules, Irreversible Covalent Inhibitors, Metabolically Activated Prodrugs
- Countries
- 2
01
Overview
A Phase 3 trial of imiquimod in actinic keratosis (AK), sponsored by Graceway Pharmaceuticals. Started May 2009; status: completed.
02
Drugs
imiquimod
03
Conditions
actinic keratosis (AK)
Beyond the preview
Go deeper on NCT00894647.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00894647.